MISSISSIPPI LEGISLATURE

2014 Regular Session

To: Judiciary A

By: Representatives Mims, Baria, Carpenter

House Bill 1231

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO REVISE THE LISTING OF HALLUCINOGENIC SUBSTANCES IN SCHEDULE I; TO AMEND SECTION 41-29-119, MISSISSIPPI CODE OF 1972, TO ADD LORCASERIN TO SCHEDULE IV; AND FOR RELATED PURPOSES.

     BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI:

     SECTION 1.  Section 41-29-113, Mississippi Code of 1972, is amended as follows:

     41-29-113.  The controlled substances listed in this section are included in Schedule I.

SCHEDULE I

     (a)  Opiates.  Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

          (1)  Acetyl-alpha-methylfentanyl;

          (2)  Acetylmethadol;

          (3)  Allylprodine;

          (4)  Alphacetylmethadol, except levo-alphacetylmethadol (levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);

          (5)  Alphameprodine;

          (6)  Alphamethadol;

          (7)  Alpha-methylfentanyl;

          (8)  Alpha-methylthiofentanyl;

          (9)  Benzethidine;

          (10)  Betacetylmethadol;

          (11)  Beta-hydroxyfentanyl;

          (12)  Beta-hydroxy-3-methylfentanyl;

          (13)  Betameprodine;

          (14)  Betamethadol;

          (15)  Betaprodine;

          (16)  Clonitazene;

          (17)  Dextromoramide;

          (18)  Diampromide;

          (19)  Diethylthiambutene;

          (20)  Difenoxin;

          (21)  Dimenoxadol;

          (22)  Dimepheptanol;

          (23)  Dimethylthiambutene;

          (24)  Dioxaphetyl butyrate;

          (25)  Dipipanone;

          (26)  Ethylmethylthiambutene;

          (27)  Etonitazene;

          (28)  Etoxeridine;

          (29)  Furethidine;

          (30)  Hydroxypethidine;

          (31)  Ketobemidone;

          (32)  Levomoramide;

          (33)  Levophenacylmorphan;

          (34)  3-methylfentanyl;

          (35)  3-methylthiofentanyl;

          (36)  Morpheridine;

          (37)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

          (38)  Noracymethadol;

          (39)  Norlevorphanol;

          (40)  Normethadone;

          (41)  Norpipanone;

          (42)  Para-fluorofentanyl;

          (43)  PEPAP (1-(-2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

          (44)  Phenadoxone;

          (45)  Phenampromide;

          (46)  Phenomorphan;

          (47)  Phenoperidine;

          (48)  Piritramide;

          (49)  Proheptazine;

          (50)  Properidine;

          (51)  Propiram;

          (52)  Racemoramide;

          (53)  Thiofentanyl;

          (54)  Tilidine;

          (55)  Trimeperidine.

     (b)  Opiate derivatives.  Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

          (1)  Acetorphine;

          (2)  Acetyldihydrocodeine;

          (3)  Benzylmorphine;

          (4)  Codeine methylbromide;

          (5)  Codeine-N-Oxide;

          (6)  Cyprenorphine;

          (7)  Desomorphine;

          (8)  Dihydromorphine;

          (9)  Drotebanol;

          (10)  Etorphine; (except hydrochloride salt);

          (11)  Heroin;

          (12)  Hydromorphinol;

          (13)  Methyldesorphine;

          (14)  Methyldihydromorphine;

          (15)  Monoacetylmorphine;

          (16)  Morphine methylbromide;

          (17)  Morphine methylsulfonate;

          (18)  Morphine-N-Oxide;

          (19)  Myrophine;

          (20)  Nicocodeine;

          (21)  Nicomorphine;

          (22)  Normorphine;

          (23)  Pholcodine;

          (24)  Thebacon.

     (c)  Hallucinogenic substances.  Any material, compound, mixture or preparation which contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric) and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

          (1)  3,4-methylenedioxy amphetamine;

          (2)  5-methoxy-3,4-methylenedioxy amphetamine;

          (3)  2,5-dimethoxy-4-ethylamphetamine (DOET);

          (4)  2,5-dimethoxy-4(n) propylthiophenethylamine (2C-T-7);

          (5)  2-(2,4-Dimethoxy-4-ethylphenyl)ethanamine(2C-E);

          (6)  2-(2,5-Dimethoxy-4-methylphenyl)ethanamine(2C-D);

          (7)  2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine(2C-C);

          (8)  2-(4-Iodo-2,5-dimethoxyphenylz)ethanamine(2C-1);

          (9)  2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine(2C-T-2);

          (10)  2[4(Isopropylthio)-2,5dimethoxyphenyl] ethanamine(2C-T-4);

          (11)  2-(2,5-Dimethoxyphenyl)ethanamine(2C-H);

          (12)  2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine(2C-N);

          (13)  2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine(2C-P);

          ( * * *514)  3,4-methylenedioxymethamphetamine (MDMA);

          ( * * *615)  3,4,5-trimethoxy amphetamine;

          ( * * *716)  Alpha-methyltryptamine (Also known as AMT);

          ( * * *817)  Bufotenine;

          ( * * *918)  Diethyltryptamine;

          ( * * *1019)  Dimethyltryptamine;

          ( * * *1120)  5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT);

          ( * * *1221)  5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);

          ( * * *1322)  Alpha-ethyltryptamine;

          ( * * *1423)  4-methyl-2,5-dimethoxyamphetamine;

          ( * * *1524)  Hashish;

          ( * * *1625)  Ibogaine;

          ( * * *1726)  Lysergic acid diethylamide (LSD);

          ( * * *1827)  Marihuana;

          ( * * *1928)  Mescaline;

          ( * * *2029)  Peyote;

          ( * * *2130)  N-ethyl-3-piperidyl benzilate;

          ( * * *2231)  N-methyl-3-piperidyl benzilate;

          ( * * *2332)  Phencyclidine;

          ( * * *2433)  Psilocybin;

          ( * * *2534)  Psilocyn;

          ( * * *2635)  Tetrahydrocannabinols, meaning tetrahydrocannabinols contained in a plant of the genus Cannabis (cannabis plant), as well as the synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant such as the following:

               (A)  -1 cis or trans tetrahydrocannabinol;

               (B)  -6 cis or trans tetrahydrocannabinol;

               (C)  -3,4 cis or trans tetrahydrocannabinol.

     (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of atomic positions are covered.)

     ("Tetrahydrocannabinols" excludes dronabinol and nabilone.)

     However, the following products are exempted from control:  THC-containing industrial products (e.g., (i) paper, rope and clothing made from cannabis stalks); (ii) processed cannabis plant materials used for industrial purposes, such as fiber retted from cannabis stalks for use in manufacturing textiles or rope; (iii) animal feed mixtures that contain sterilized cannabis seeds and other ingredients (not derived from the cannabis plant) in a formula designed, marketed and distributed for nonhuman consumption; and (iv) personal care products that contain oil from sterilized cannabis seeds, such as shampoos, soaps, and body lotions (provided that such products do not cause THC to enter the human body);

          (27)  2,5-dimethoxyamphetamine;

          (28)  4-bromo-2,5-dimethoxyamphetamine;

          (29)  4-bromo-2,5-dimethoxyphenylethylamine;

          (30)  4-methoxyamphetamine;

          (31)  Ethylamine analog of phencyclidine (PCE);

          (32)  Pyrrolidine analog of phencyclidine (PHP, PCPy);

          (33)  Thiophene analog of phencyclidine;

          (34)  Parahexyl;

          (35)  1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy);

          (36)  3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenylethylamine, N-ethyl MDA, MDE, MDEA);

          (37)  N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy MDA, N-OHMDA, and N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenylethylamine);

          (38)  Salvia divinorum;

          (39)  Synthetic cannabinoids:

               (A)  (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol (also known as HU-210 or 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol);

               (B)  Naphthoylindoles and naphthylmethylindoles, being any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted in the indole ring to any extent, or in the naphthyl ring to any extent;

               (C)  Naphthoylpyrroles, being any compound structurally derived from 3-(1-naphthoyl)pyrrole, whether or not substituted in the pyrrole ring to any extent, or in the naphthyl ring to any extent;

               (D)  Naphthylmethylindenes, being any compound structurally derived from 1-(1-naphthylmethyl)indene, whether or not substituted in the indene ring to any extent or in the naphthyl ring to any extent;

               (E)  Phenylacetylindoles, being any compound structurally derived from 3-phenylacetylindole, whether or not substituted in the indole ring to any extent or in the phenyl ring to any extent;

               (F)  Cyclohexylphenols, being any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether or not substituted in the cyclohexyl ring to any extent or in the phenolic ring to any extent;

               (G)  Benzoylindoles, whether or not substituted in the indole ring to any extent or in the phenyl ring to any extent;

               (H)  Adamantoylindoles, whether or not substituted in the indole ring to any extent or in the adamantoyl ring system to any extent;

               (I)  Tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabiniol or of its tetrahydro derivatives, except where contained in cannabis or cannabis resin.

     (d)  Depressants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

          (1)  Gamma-hydroxybutyric acid (other names include:  GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);

          (2)  Mecloqualone;

          (3)  Methaqualone.

     (e)  Stimulants.  Any material, compound, mixture or preparation which contains any quantity of the following central nervous system stimulants including optical salts, isomers and salts of isomers unless specifically excepted or unless listed in another schedule:

          (1)  Aminorex;

          (2)  N-benzylpiperazine (also known as BZP; 1-benzylpiperazine);

          (3)  Fenethylline;

          (4)  N-ethyl-amphetamine;

          (5)  4-methylaminorex (also known as 2-amino-4-methyl-5-phenyl-2-oxazoline);

          (6)  Any material, compound, mixture or preparation which contains any quantity of N,N-dimethylamphetamine.  (Other names include:  N,N,-alpha-trimethyl-benzeneethanamine, and N,N-alphatrimethylphenethylamine);

          (7)  Cathinone, methcathinone, 4-methylmethcathinone (mephedrone), methylenedioxypyrovalerone (MDPV), and, unless listed in another schedule, any compound other than bupropion that is structurally derived from 2-Amino-1-phenyl-1-propanone by modification in any of the following ways:

               (i)  By substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

               (ii)  By substitution at the 3-position with an alkyl substituent;

               (iii)  By substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.

     SECTION 2.  Section 41-29-119, Mississippi Code of 1972, is amended as follows:

     41-29-119.  (A)  The controlled substances listed in this section are included in Schedule IV.

SCHEDULE IV

          (a)  Narcotic drugs.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains limited quantities of the following narcotic drugs, or any salts thereof:

               (1)  Not more than one (1) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit;

               (2)  Dextropropoxyphene, including its salts (Darvon, Darvon-N; also found in Darvon compound and Darvocet-N, etc.).

          (b)  Depressants.  Any material, compound, mixture or preparation which contains any quantity of the following substances:

               (1)  Alprazolam;

               (2)  Barbital;

               (3)  Bromazepam;

               (4)  Camazepam;

               (5)  Carisoprodol;

               (6)  Chloral betaine;

               (7)  Chloral hydrate;

               (8)  Chlordiazepoxide and its salts, but does not include chlordiazepoxide hydrochloride and clidinium bromide or chlordiazepoxide and esterified estrogens;

               (9)  Clobazam;

               (10)  Clonazepam;

               (11)  Clorazepate;

               (12)  Clotiazepam;

               (13)  Cloxazolam;

               (14)  Delorazepam;

               (15)  Diazepam;

               (16)  Dichloralphenazone;

               (17)  Estazolam;

               (18)  Ethchlorvynol;

               (19)  Ethinamate;

               (20)  Ethyl loflazepate;

               (21)  Fludiazepam;

               (22)  Flunitrazepam;

               (23)  Flurazepam;

               (24)  Fospropofol;

               (25)  Halazepam;

               (26)  Haloxazolam;

               (27)  Ketazolam;

               (28)  Loprazolam;

               (29)  Lorazepam;

               (30)  Lormetazepam;

               (31)  Mazindol;

               (32)  Mebutamate;

               (33)  Medazepam;

               (34)  Meprobamate;

               (35)  Methohexital;

               (36)  Methylphenobarbital;

               (37)  Midazolam;

               (38)  Nimetazepam;

               (39)  Nitrazepam;

               (40)  Nordiazepam;

               (41)  Oxazepam;

               (42)  Oxazolam;

               (43)  Paraldehyde;

               (44)  Petrichloral;

               (45)  Phenobarbital;

               (46)  Pinazepam;

               (47)  Prazepam;

               (48)  Quazepam;

               (49)  Temazepam;

               (50)  Tetrazepam;

               (51)  Triazolam;

               (52)  Zaleplon;

               (53)  Zolpidem;

               (54)  Zopiclone.

          (c)  Fenfluramine.

          (d)  Lorcaserin.  Any material, compound, mixture, or preparation which contains any quantity of Lorcaserin, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible.

          ( * * *deStimulants.  Any material, compound, mixture or preparation which contains any quantity of the following substances:

               (1)  Diethylpropion;

               (2)  Phentermine;

               (3)  Pemoline (including any organometallic complexes and chelates thereof);

               (4)  Pipradrol;

               (5)  Sibutramine;

               (6)  SPA ((-)-1-dimethylamino-1,2-diphenylethane).

               (7)  Cathine ((+/-) Norpseudoephedrine);

               (8)  Fencamfamin;

               (9)  Fenproporex;

               (10)  Mefenorex;

               (11)  Modafinil.

          ( * * *efOther substances.  (1)  Butorphanol (including its optical isomers);

               (2)  Tramadol.

     (B)  Any material, compound, mixture or preparation which contains any quantity of a Schedule IV controlled substance and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.

     SECTION 3.  This act shall take effect and be in force from and after July 1, 2014.